Avadel Pharmaceuticals plc ADR buy BiotechBee
Start price
17.07.23
/
70%
€13.60
Target price
31.12.25
€23.00
Performance (%)
11.03%
End price
14.12.24
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 11.03%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avadel Pharmaceuticals plc ADR | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
According to BiotechBee what are the pros and cons of Avadel Pharmaceuticals plc ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Avadel Pharmaceuticals plc ADR diskutieren
Buy mit Kursziel 23,0
In the thread Trading Avadel Pharmaceuticals plc ADR
Buy beendet

